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Abstract
 
TANK-binding kinase-1 (TBK1) and the inducible I
 
 
 
B kinase (IKK-
 
i
 
) have been shown recently
to activate interferon (IFN) regulatory factor-3 (IRF3), the primary transcription factor regulating
induction of type I IFNs. Here, we have compared the role and specificity of TBK1 in the type
I IFN response to lipopolysaccharide (LPS), polyI:C, and viral challenge by examining IRF3
nuclear translocation, signal transducer and activator of transcription 1 phosphorylation, and
induction of IFN-regulated genes. The LPS and polyI:C-induced IFN responses were abol-
ished and delayed, respectively, in macrophages from mice with a targeted disruption of the
TBK1 gene. When challenged with Sendai virus, the IFN response was normal in TBK1
 
   
 
macrophages, but defective in TBK1
 
   
 
 embryonic fibroblasts. Although both TBK1 and
IKK-
 
i
 
 are expressed in macrophages, only TBK1 but not IKK-
 
i
 
 was detected in embryonic
fibroblasts by Northern blotting analysis. Furthermore, the IFN response in TBK1
 
   
 
 embry-
onic fibroblasts can be restored by reconstitution with wild-type IKK-
 
i
 
 but not a mutant IKK-
 
i
 
lacking kinase activity. Thus, our studies suggest that TBK1 plays an important role in the Toll-
like receptor–mediated IFN response and is redundant with IKK-
 
i
 
 in the response of certain cell
types to viral infection.
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Introduction
 
In the evolutionary battle between viruses and their multi-
cellular hosts, type I IFNs have emerged as critical mediators
of host defense (1). Type I IFNs, including IFN
 
 
 
 and
IFN
 
 
 
, are cytokines that are transcriptionally induced dur-
ing viral infection and that signal through the type I IFN
 
 
 
/
 
 
 
 receptor (IFNAR) to activate transcription of a large
set of genes important in antiviral responses (2). IFN
 
 
 
 is
first produced in response to the signaling cascade activated
by innate immune viral detection and its transcription is
controlled largely by the IFN regulatory factor-3 (IRF3)
transcription factor (3–5).
IRF3 is localized in the cytoplasm in unstimulated cells
and, upon stimulation, becomes activated by serine/threo-
nine phosphorylation leading to nuclear translocation (4).
IRF7, a close homologue of IRF3, is transcriptionally in-
duced by IFNAR signaling and acts to promote further
production of type I IFN (5–7). After production, IFN
 
 
 
/
 
 
 
binds to IFNAR in both an autocrine and paracrine man-
ner and initiates activation of the Janus kinase (JAK)–signal
transducer and activator of transcription (STAT) signaling
pathway (2, 5). This activates the IFN-stimulated gene
factor-3 transcription factor complex consisting of IRF-9,
STAT1, and STAT2. IFN-stimulated gene factor-3 binds
to IFN-stimulated response elements present in promoters
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Abbreviations used in this paper:
 
 BMM, BM-derived macrophage; IFNAR,
type I IFN 
 
 
 
/
 
 
 
 receptor; IKK-
 
i
 
, inducible I
 
 
 
B kinase; IRF3, IFN regula-
tory factor-3; JAK, Janus kinase; KA, kinase-inactive; MEF, immortalized
murine embryonic fibroblast; Q-PCR, quantitative RT-PCR; SeV,
Sendai virus; STAT, signal transducer and activator of transcription;
TBK1, TANK-binding kinase-1; TLR, Toll-like receptor; TRAM, TRIF-
related adaptor molecule; TRIF, Toll/IL-1 receptor domain–containing
adaptor-inducing IFN-
 
 
 
. 
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of a large set of target genes important in antiviral responses
(2, 5).
Toll-like receptors (TLRs) are a family of pattern recog-
nition receptors that are known to recognize conserved
microbial motifs and to subsequently induce signaling cas-
cades that lead to proinflammatory cytokine production
and maturation of antigen-presenting cells as well as en-
hancement of phagocytic activity of macrophages (8, 9).
Several TLRs are able to recognize viral products including
dsRNA (TLR3), the F protein of respiratory syncytial virus
(TLR4), ssRNA and the antiviral imiquimod compounds
(TLR7), and CpG DNA (TLR9; references 10–16).
Most TLR-mediated responses proceed through the
Toll/IL-1 receptor domain–containing adaptor molecule
MyD88 to the activation of NF-
 
 
 
B and MAP kinases (17).
However, careful studies of MyD88-deficient mice revealed
a MyD88-independent pathway that contributed to DC
maturation and delayed NF-
 
 
 
B and MAP kinase activation
(18, 19). Subsequently, TLR3 and TLR4, which recognize
dsRNA and LPS respectively, were found to activate IRF3
and up-regulate a type I IFN–dependent gene program in a
MyD88-independent manner and became characteristic of
this pathway (20, 21). Thus, the signaling mediators leading
to type I IFN production during TLR3/4 stimulation have
been under heavy study. Recently, two additional adaptor
molecules were identified as missing links between TLR3/4
and IRF3. Mice deficient in Toll/IL-1 receptor domain–
containing adaptor-inducing IFN-
 
 
 
 (TRIF/TICAM-1) were
found to have defective type I IFN production and late
NF-
 
 
 
B activation in response to stimulation of either TLR3
or TLR4, whereas mice deficient in TRIF-related adaptor
molecule (TRAM/TICAM-2) were defective in these re-
sponses only during TLR4 stimulation (22–28).
TANK-binding kinase-1 (TBK1; T2K, NAK) and in-
ducible I
 
 
 
B kinase (IKK-
 
i
 
; IKK
 
 
 
) were known previously
as relatives of the IKKs that had an undefined role in NF-
 
 
 
B activation and might potentially act as IKK kinases (29).
Recently, TBK1 and IKK-
 
i
 
 were identified as having the
ability to induce in vitro phosphorylation of IRF3 and
IRF7 and to activate a luciferase reporter driven by the
IFN
 
 
 
 promoter (30, 31). However, the specificity of
TBK1 and IKK-
 
i
 
 in type I IFN production by TLR3,
TRL4, and viral stimulations remains to be elucidated.
In this paper, we further characterize the contribution of
TBK1 in TLR3/4 signaling pathways and during viral in-
fections in cells derived from TBK1
 
   
 
 mice. We provide
genetic evidence that TBK1 is required for IRF3 activation
and production of type I IFN genes in response to TLR3
and TLR4 ligands, but not for NF-
 
 
 
B activation. Interest-
ingly, during virus infection, a cell type–specific require-
ment for TBK1 was observed in which embryonic fibro-
blasts but not macrophages required TBK1. We suggest that
differential expression of IKK-
 
i
 
 may mediate this difference.
 
Materials and Methods
 
Mice and Cell Culture.
 
Generation of mice with a targeted
disruption of the TBK1 gene have been described previously
(32). TBK1
 
   
 
 mice were generated by crossing mice heterozy-
gous for a TBK1-deficient allele with TNFR1
 
   
 
 mice (provided
by T. Mak, University of Toronto, Toronto, Canada) for two
generations to get TBK1
 
   
 
TNFR1
 
   
 
 mice. BM–derived mac-
rophages (BMMs) differentiated from marrow from 6–10-wk-old
TBK1
 
   
 
TNFR1
 
   
 
 mice and TBK1
 
   
 
TNFR1
 
   
 
 or TBK1
 
   
 
TNFR1
 
   
 
 littermates were generated as described previously
(33). In brief, BM cells were harvested from mice and allowed to
differentiate for 7–8 d in 30% L929-conditioned media before as-
says were performed. TBK1 wild type and knockout immortal-
ized murine embryonic fibroblasts (MEFs) have been described
previously (32).
 
Virus Infections and Reagents.
 
BMMs were stimulated with
LPS (Sigma-Aldrich) at 10 ng/ml and polyI:C (Amersham Bio-
sciences) at 1 
 
 
 
g/ml. Sendai virus (SeV; Z strain) was a gift from
D. Nayak (University of California Los Angeles, Los Angeles,
CA; reference 34). Cells were infected at a multiplicity of infec-
tion of approximately five for the time points indicated.
 
Protein Extracts, Immunoblotting, and EMSA.
 
Cell lysates were
fractionated into nuclear and cytoplasmic fractions as described
previously (20). Nuclear fractions were probed with antibodies
against IRF3 (Zymed Laboratories), p65, and USF2 (Santa Cruz
Biotechnology, Inc.). Cytoplasmic fractions were probed with
antibodies against phosphorylated STAT1 (pY701; Cell Signaling
Technology) and STAT1 (Santa Cruz Biotechnology, Inc.). For
EMSA, nuclear fractions were used in binding reactions with a
 
 
 
[
 
32
 
P]-labeled NF-
 
 
 
B–specific oligonucleotide as described pre-
viously (35).
 
Vectors and Reconstituted Cell Lines.
 
Full length and kinase-
inactive (KA; K38A) mutant forms of TBK1 and IKK-
 
i
 
 were
cloned from human expressed sequence tags (American Type
Culture Collection) into the pEBB eukaryotic expression vector
containing a puromycin-resistant gene. Vectors were transfected
into TBK1
 
   
 
 MEFs and stably expressing cell lines were selected
in the presence of 2.5 
 
 
 
g/ml puromycin.
 
Quantitative Real-Time PCR and Northern Blot Analysis.
 
RNA was isolated using TRIzol (Invitrogen), and cDNA was
synthesized using iScript (Bio-Rad Laboratories) according to the
manufacturer’s instructions. Quantitative RT-PCR (Q-PCR)
analysis was performed using the iCycler thermocycler (Bio-Rad
Laboratories) as described previously (20). Primer sequences for
IFN
 
 
 
, IP-10, IRF7, TNF
 
 
 
, I
 
 
 
B
 
 
 
, ICAM-1, and L32 have been
described previously (20, 36). The following IL-15 primers were
used: F, 5
 
 
 
-CACTTTTTAACTGAGGCTGGCATT-3
 
 
 
; and
R, 5
 
 
 
-TCCAGTTGGCCTCTGTTTTAGG-3
 
 
 
. The following
primers were used: IFN
 
 
 
5, F, 5
 
 
 
-TGACCTCAAAGCCTGT-
GTGATG-3
 
 
 
 and R, 5
 
 
 
-AAGTATTTCCTCACAGCCAG-
CAG-3
 
 
 
; and Mx1 primers, F, 5
 
 
 
-AAACCTGATCCGACT-
TCACTTCC-3
 
 
 
, and R, 5
 
 
 
-TGATCGTCTTCAAGGTTTC-
CTTGT-3
 
 
 
. All gene expression data presented were normalized
to L32 levels for each sample.
Northern blot analysis was performed using standard proce-
dures. Probes for detection of TBK1 and IKK-
 
i
 
 were PCR am-
plified from full-length human expressed sequence tags and la-
beled with 
 
 
 
[
 
32
 
P].
 
Results
 
TBK1 Is Required for LPS-induced IRF3 Activation and
Type I IFN Production.
 
The LPS-induced type I IFN re-
sponse through TLR4 involves TRAM and TRIF-depen-
dent, but MyD88-independent activation of IRF3 and 
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transcriptional up-regulation of a subset of primary re-
sponse genes including IFN
 
 
 
. Subsequently, activation of
the JAK–STAT pathway and up-regulation of a subset of
secondary response genes occurs through auto/paracrine
activity of type I IFNs (2, 20–28). To examine the role of
TBK1 in LPS-induced activation of the type I IFN re-
sponse, activation of IRF3 and STAT1 and induction of
IFN-regulated genes was compared in TBK1
 
   
 
 and
TBK1
 
   
 
 BMMs at various time points after LPS stimula-
tion. Although strong IRF3 nuclear translocation and
STAT1 phosphorylation was observed in TBK1
 
   
 
 BMMs
upon LPS stimulation, this response was either completely
absent or greatly diminished in BMMs lacking TBK1 (Fig.
1, A and B). In response to LPS, TBK1
 
   
 
 BMMs also
failed to up-regulate transcription of IFN
 
 
 
 and IFN-medi-
ated transcription of genes including IP-10, IFN
 
 
 
5, IRF7,
IL-15, and Mx1 (Fig. 1 C). Because TBK1-deficient mice
are embryonically lethal, TBK1
 
 
 
/
 
 
 
 BMMs used here and
in the subsequent experiments were derived from TBK1
and TNFR1 double knockout mice, which are viable. Al-
though controls used in experiments shown in Figs. 1–4
are BMMs from TBK1
 
   
 
TNFR1
 
   
 
 mice, similar results
were obtained with BMMs from TBK1
 
   
 
TNFR1
 
   
 
mice (unpublished data). Thus, TBK1 is an essential and
nonredundant component of LPS-induced IRF3 activation
and type I IFN responses.
 
TBK1 Is Required for dsRNA-mediated IRF3 Activation and
Early But Not Late Induction of Type I IFN Responses.
 
The
dsRNA analogue, polyI:C, can induce type I IFN re-
sponses through both TLR3-dependent and -independent
mechanisms (10, 24, 37). To determine the requirement
for TBK1 in type I IFN responses induced by dsRNA
signaling pathways, the effect of polyI:C stimulation on
TBK1
 
   
 
 BMMs was analyzed. Similar to that seen with
LPS stimulation, BMMs lacking TBK1 were unable to in-
duce nuclear translocation of IRF3 in response to polyI:C
(Fig. 2 A). Even during evaluation of an extended time
course (up to 4 h after stimulation), IRF3 nuclear localiza-
tion remained undetectable in TBK1
 
   
 
 BMMs (unpub-
lished data). However, unlike what was observed for
LPS stimulation, polyI:C-induced STAT1 phosphorylation
could be detected in TBK1
 
   
 
 BMMs, albeit with delayed
kinetics (Fig. 2 B). Gene expression analyses showed that
IFN
 
 
 
 production was absent in TBK1
 
   
 
 BMMs in re-
sponse to polyI:C (Fig. 2 C). However, induction of sec-
ondary IFN-regulated genes, such as IP-10, IFN
 
 
 
5, IRF7,
IL-15, and Mx1, were induced in a delayed fashion in
TBK1
 
   
 
 BMMs (Fig. 2 C and not depicted). Thus, in re-
sponse to polyI:C, TBK1 is required for IRF3 activation
and IFN
 
 
 
 production; however, there appears to be a
TBK1-independent pathway that can up-regulate delayed
IFN
 
 
 
 and type I IFN–regulated gene production.
 
Activation of NF-
 
 
 
B in Response to LPS and PolyI:C Does
Not Require TBK1. TBK1 is an IKK family member and
was initially suggested to have a role in NF- B activation
(38, 39). To determine if TBK1 has a role in the NF-
 B response to LPS or polyI:C, stimulated TBK1    and
TBK1    BMMs were assayed for activation of NF- B us-
ing EMSA and by immunoblotting nuclear protein frac-
Figure 2. TBK1-deficient BMMs have defective type I IFN responses
to polyI:C. TBK1   TNFR1    and TBK1   TNFR1    BMMs were
stimulated with 1  g/ml polyI:C for the indicated time points. (A) Nuclear
fractions were probed for IRF3 and USF2 as a loading control. (B) Total
cell extracts were probed for phospho-STAT1 and total STAT1. (C) Total
RNA was extracted and analyzed by Q-PCR for expression of IFN ,
IP-10, IFN 5, IRF7, IL-15, and Mx1.
Figure 1. TBK1 is required for LPS-mediated activation of type I IFN
responses. TBK1   TNFR1    and TBK1   TNFR1    BMMs were
stimulated with 10 ng/ml LPS for the indicated time points. (A) Nuclear
fractions were probed for IRF3 and USF2 as a loading control for nuclear
proteins. (B) Total cell extracts were probed for phospho-STAT1 and
total STAT1. (C) Total RNA was extracted and analyzed by Q-PCR for
expression of IFN , IP-10, IFN 5, IRF7, IL-15, and Mx1.Requirement for TBK1 in Type I Interferon Responses 1654
tions for p65, the major NF- B subunit. Neither assay in-
dicated a defect in NF- B activation in response to LPS or
polyI:C in TBK1    BMMs (Fig. 3, A and B). Further-
more, Q-PCR analyses of the NF- B–regulated genes
ICAM-1 and I B  revealed similar induction in TBK1   
and TBK1    BMMs after LPS or polyI:C stimulation (Fig.
3 C). Thus, TBK1 is not required for NF- B activation in
response to either LPS or polyI:C.
TBK1 Is Not Required for SeV-induced IRF3 Activation in
BMMs. Type I IFN production is a characteristic re-
sponse of virally infected cells. TLR3 activation by viral
dsRNA may mediate some aspects of viral recognition
leading to type I IFN responses. However, it is unclear
how different host cells detect various viruses and induce
type I IFN responses during an actual infection. To deter-
mine the role for TBK1 in activation of the IFN response
during an in vitro virus infection, we infected BMMs with
SeV, a negative-stranded RNA virus. Surprisingly, in con-
trast to polyI:C stimulation, nuclear localization of IRF3
was normal in TBK1    BMMs during SeV infection (Fig.
4 A). Furthermore, although TBK1 mediated early induc-
tion of polyI:C-induced STAT1 phosphorylation, compa-
rable kinetics and levels of STAT1 phosphorylation were
observed between TBK1    and TBK1    BMMs infected
with SeV (Fig. 4 B). In accordance with normal STAT1
kinetics, production of IFN  and the IFN-regulated genes
IP-10, IFN 5, IRF7, IL-15, or Mx1 were comparable in
TBK1    and TBK1    BMMs during SeV infection (Fig.
4 C). Activation of NF- B and NF- B–regulated gene in-
duction was normal in TBK1    BMMs (unpublished
data). Thus, although TBK1 mediates IRF3 activation and
IFN  production as well as prompt induction of IFN-reg-
ulated genes in response to polyI:C, a TBK1-indepen-
dent pathway exists for these responses during infection of
BMMs with an RNA virus.
A Cell Type–dependent Requirement for TBK1 in Response
to Virus Infection. In addition to BMMs, we analyzed the
requirement for TBK1 during SeV infection of several
other cell types to determine if all cells can activate IFN re-
sponses independently of TBK1. Infection of thymocytes
with SeV showed comparable kinetics and levels of STAT1
phosphorylation in TBK1    and TBK1    thymocytes,
indicating that TBK1 is not required for IFN responses in
thymocytes (unpublished data).
We also examined the role for TBK1 in IRF3 activation
during SeV infections in immortalized MEFs derived from
wild-type and TBK1    littermates. In contrast with our ob-
servations in BMMs and thymocytes, IRF3 nuclear localiza-
Figure 3. TBK1-deficient BMMs induce normal NF- B responses to
LPS and polyI:C. TBK1   TNFR1 /  and TBK1   TNFR1    BMMs
were stimulated with 10 ng/ml LPS or 1  g/ml polyI:C for the indicated
time points. (A) Nuclear fractions were probed for p65 and USF2 as a
loading control. (B) EMSA was performed by incubating nuclear extracts
were with an NF- B-specific oligonucleotide. (C) Total RNA was ex-
tracted and analyzed by Q-PCR for expression of ICAM1 and I B .
Figure 4. TBK1-deficient
BMMs have normal IFN responses
to SeV. TBK1   TNFR1    and
TBK1   TNFR1    BMMs were
infected with SeV for the indicated
time points. (A) Nuclear fractions
were probed for IRF3 and USF2 as
a loading control. (B) Total cell ex-
tracts were probed for phospho-
STAT1 and total STAT1. (C) Total
RNA was extracted and analyzed by
Q-PCR for expression of IFN , IP-
10, IFN 5, IRF7, IL-15, and Mx1.Perry et al. 1655
tion in response to SeV was absent in MEFs lacking TBK1
(Fig. 5 A). STAT1 phosphorylation was also largely reduced
in TBK1    MEFs (Fig. 5 A). Furthermore, TBK1    MEFs
failed to induce expression of IFN , IP-10, IRF7, or IL-15
in response to SeV infection (Fig. 5 B). However, NF- B
activation was unaffected as assessed by EMSA, p65 nuclear
localization, and analysis of induction of I B  and ICAM-1
genes (Fig. 5, C–E). Thus, we have observed a cell type–
dependent requirement for TBK1 in the activation of IFN
responses during infection with SeV, and have found a require-
ment for TBK1 in MEFs, but not in BMMs or thymocytes.
Differential Expression of IKK-i May Be Responsible for Cell
Type–dependent Requirements for TBK1 in Viral Activation of
IFN Responses. In addition to TBK1, IKK-i has also been
identified as a putative IRF3 and IRF7 kinase (30, 31).
IKK-i has been shown to be preferentially expressed in spe-
cific tissues, including spleen and peripheral blood lympho-
cytes, and expression can be induced in response to LPS and
proinflammatory cytokines (40). We sought to determine if
differential expression of IKK-i may mediate the discrep-
ancy we observed when comparing the requirement for
TBK1 in BMMs versus MEFs during SeV infection. Thus,
we analyzed basal expression levels of IKK-i and TBK1
mRNA in BMMs and MEFs by Northern blot analysis.
Similar expression levels of TBK1 were observed in BMMs
and MEFs (Fig. 6 A). However, analysis of IKK-i mRNA
levels in these cell types revealed strong expression in
BMMs, whereas wild-type MEFs had barely detectable lev-
els of IKK-i and these levels were even lower in TBK1   
MEFs (Fig. 6 A).
We determined if the introduction of IKK-i into TBK1   
MEFs could rescue SeV-mediated IRF3 activation. TBK1   
MEFs were stably transfected with vectors encoding either
TBK1 or IKK-i or their respective KA versions, harboring a
single K38A substitution shown to inactivate kinase activity
(29, 38–40). Reconstituted cells were infected with SeV,
and IRF3 nuclear localization was analyzed. TBK1    MEFs
reconstituted with wild-type TBK1 but not KA TBK1
(TBK1-KA) were able to induce IRF3 nuclear localization,
IFN  production, and STAT1 phosphorylation similarly to
wild-type MEFs (Fig. 6, B and C). In addition, TBK1   
MEFs reconstituted with IKK-i could also rescue the defi-
ciency of TBK1. This was dependent on the kinase activity
of IKK-i as KA IKK-i (IKK-i–KA) could not rescue IRF3
activation, STAT1 phosphorylation, or IFN  production
(Fig. 6, B and C). Thus, IKK-i is able to mediate IRF3 acti-
vation in response to SeV in the absence of TBK1. Hence,
our data indicate that IKK-i may be playing a redundant role
with TBK1 during virus-induced IFN responses in cell types
that express sufficient levels of IKK-i.
Discussion
Production of type I IFNs is critical to the host immune
defense against viral infection and is a hallmark of virally in-
fected cells. Induction of antiviral IFN responses can also
occur as a result of TLR3/4 ligand stimulation. Although
virtually all cell types can elicit an IFN response during vi-
ral infection, expression of TLRs is more restricted to im-
mune cells and, thus, TLR-induced antiviral responses may
be primarily important in these cell types. As the pathways
involved in TLR3/4-induced type I IFN production are
being carefully studied, an interesting question remains un-
answered regarding the role of these pathways and signaling
Figure 5. TBK1-deficient MEF cells have impaired IFN
responses to SeV. Wild-type and TBK1    MEF cells were
infected with SeV for the indicated time points. (A) Nuclear
fractions were probed for IRF3 and USF2 as a loading
control. Total cell extracts were probed for phospho-
STAT1 and total STAT1. (B) Total RNA was extracted
and analyzed by Q-PCR for expression of IFN , IP-10,
IRF7, and IL-15. (C) EMSA was performed by incubating
nuclear extracts were with an NF- B-specific oligonu-
cleotide. (D) Nuclear fractions were probed for p65 and
USF2. (E) Total RNA was extracted and analyzed by
Q-PCR for expression of ICAM1 and I B .Requirement for TBK1 in Type I Interferon Responses 1656
mediators during viral infections. In this work, we compare
the role of the kinase TBK1 in IFN responses induced by
LPS, polyI:C, and SeV. We have found a requirement for
TBK1 in IRF3 activation and IFN  production in re-
sponse to LPS and polyI:C. However, during infection
with SeV, we have found a cell type–dependent require-
ment for TBK1 for induction of IFN responses.
In response to LPS, BMMs derived from TBK1    mice
were found to be defective in their ability to activate IRF3
and up-regulate IFN  production. Furthermore, LPS in-
duction of IFN-regulated secondary response genes was also
TBK1 dependent. Thus, our data demonstrate that although
IKK-i is coexpressed in BMMs, TBK1 plays a nonredun-
dant role as the LPS-activated IRF3 kinase. Previous studies
have also shown that cells from mice lacking TLR4, TRIF,
or TRAM are completely defective in LPS-induced IRF3
activation and IFN production (21, 23, 24, 27). In addition,
IRF3 is essential for LPS-mediated type I IFN responses
(reference 41 and unpublished data). Therefore, our studies
are consistent with a model of LPS-induced IFN induction
proceeding through a linear signaling pathway dependent
on TLR4, TRAM, TRIF, TBK1, and IRF3.
IRF3 activation and IFN  production in response to
polyI:C was also found to be dependent on TBK1. Previ-
ous studies have shown that TBK1 can interact with TRIF
and phosphorylate IRF3 (30, 42). Therefore, it seems likely
that TBK1 mediates dsRNA induction of type I IFN
through the same pathway as TLR3, TRIF, and IRF3.
However, although TBK1 seems to be required for all
LPS-mediated IFN responses, polyI:C stimulation was able
to induce TBK1-independent STAT1 phosphorylation and
production of IFN  and IFN-regulated genes in a delayed
but significant fashion. Studies in IRF3-deficient cells show
a similar delay in STAT1 phosphorylation and induction of
secondary IFN-regulated genes (reference 41 and unpub-
lished data). Other studies have also indicated that alterna-
tive pathways exist for dsRNA induction of IFN responses.
In cells lacking TLR3 or TRIF, dsRNA stimulation is still
able to induce a delayed but significant amount of type
I IFN and IFN-mediated gene induction, potentially
mediated by protein kinase R recognition of intracellu-
lar dsRNA (10, 24, 43–45). Recently, a locus-mediating
TRIF-independent up-regulation of costimulatory mole-
cules was identified. Description of the gene mediating this
phenotype may reveal a member of this alternative pathway
(44). These studies highlight that host cells have evolved
multiple mechanisms for detection of viral invasion. This
phenomenon is particularly important because many vi-
ruses have the ability to inhibit various signaling mediators
involved in activation of antiviral IFN responses.
During infection with SeV, we found a TBK1 defi-
ciency in BMMs had minimal effects on IRF3 activation,
IFN  production, or production of IFN-regulated genes.
However, all of these responses were dramatically abro-
gated during infection of TBK1    MEFs. The cell type–
specific requirement for TBK1 during viral infection indi-
cates that alternate mechanisms exist in BMMs but not in
MEFs to phosphorylate IRF3. The related kinase IKK-i
was expressed at much higher levels in BMMs as compared
with MEFs. Reintroduction of either TBK1 or IKK-i but
not their KA mutants into TBK1    MEFs could rescue
activation of IRF3 and IFN  production, indicating that
IKK-i may be functionally redundant with TBK1 during
viral infections. Studies in IKK-i–deficient and TBK1/
Figure 6. IKK-i is differentially expressed in BMMs and MEFs, and can
rescue a TBK1 deficiency during SeV infection. (A) Total RNA extracted
from BMMs, wild-type MEFs, and TBK1    MEFs were probed by
Northern blot for expression of TBK1 and IKK-i. 28 and 18 sRNA bands
are shown as loading controls. (B) Wild-type MEFs, TBK1    MEFs, and
TBK1    MEFs reconstituted with wild-type TBK1 or IKK-i, or their
kinase-inactive (KA) mutants were infected with SeV for the time points
indicated. Nuclear fractions were probed for IRF3, p65, and USF2 as a
loading control. Total cell extracts were probed for phospho-STAT1 and
total STAT1. (C) Cells were infected with SeV as in B and total RNA was
extracted and analyzed by Q-PCR for expression of IFN .Perry et al. 1657
IKK-i double knockout mice are needed to clarify the re-
quirements for these kinases during viral infections.
TBK1 was initially identified as having a role in NF- B
activation, being able to induce NF- B activation when
overexpressed, as well as being able to in vitro phosphory-
late IKK  and Ser32 of I B  (38, 39). However, in agree-
ment with initial studies performed on TBK1    MEFs in
which the process of activating NF- B by TNF or IL-1
was not observably defective (32), our studies indicate that
TBK1 is not required for NF- B activation during either
TLR3/4 stimulation or virus infection, as neither nuclear
localization or DNA-binding ability were affected. This
observation is consistent with previous biochemical studies
indicating TLR-mediated MyD88-independent activation
of NF- B versus IRF3 responses diverge at TRIF (42).
Viruses are complex and diverse organisms and, thus,
hosts have likely evolved multiple mechanisms for detect-
ing viral invasion. Although we have characterized the role
for TBK1 in response to LPS, polyI:C, and SeV infection,
future studies are needed to address whether TBK1 plays a
similar role during infections with different viruses, as well
as to determine the role of IKK-i and other signaling medi-
ators. Furthermore, the host receptors recognizing viral
components have yet to be identified. Due to the differen-
tial requirement for TBK1 in various cell types, it will be
interesting to explore the role for TBK1 in the whole ani-
mal response during in vivo infections to determine if cell
types that elicit IFN production independently of TBK1
are sufficient for resistance to viral infection. Viruses can
inhibit induction of type I IFNs in a variety of ways, many
of which have not yet been elucidated, and further under-
standing of these pathways can help to better understand
the mechanisms of virus-mediated inhibition of the IFN
response (46).
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References
1. Muller, U., U. Steinhoff, L.F. Reis, S. Hemmi, J. Pavlovic,
R.M. Zinkernagel, and M. Aguet. 1994. Functional role of
type I and type II interferons in antiviral defense. Science. 264:
1918–1921.
2. Stark, G.R., I.M. Kerr, B.R. Williams, R.H. Silverman, and
R.D. Schreiber. 1998. How cells respond to interferons.
Annu. Rev. Biochem. 67:227–264.
3. Juang, Y.T., W. Lowther, M. Kellum, W.C. Au, R. Lin, J.
Hiscott, and P.M. Pitha. 1998. Primary activation of interferon
A and interferon B gene transcription by interferon regulatory
factor 3. Proc. Natl. Acad. Sci. USA. 95:9837–9842.
4. Taniguchi, T., K. Ogasawara, A. Takaoka, and N. Tanaka.
2001. IRF family of transcription factors as regulators of host
defense. Annu. Rev. Immunol. 19:623–655.
5. Taniguchi, T., and A. Takaoka. 2002. The interferon-alpha/
beta system in antiviral responses: a multimodal machinery of
gene regulation by the IRF family of transcription factors.
Curr. Opin. Immunol. 14:111–116.
6. Servant, M.J., B. Tenoever, and R. Lin. 2002. Overlapping
and distinct mechanisms regulating IRF-3 and IRF-7 func-
tion. J. Interferon Cytokine Res. 22:49–58.
7. Sato, M., N. Hata, M. Asagiri, T. Nakaya, T. Taniguchi, and
N. Tanaka. 1998. Positive feedback regulation of type I IFN
genes by the IFN-inducible transcription factor IRF-7. FEBS
Lett. 441:106–110.
8. Barton, G.M., and R. Medzhitov. 2003. Toll-like receptor
signaling pathways. Science. 300:1524–1525.
9. Doyle, S.E., R.M. O’Connell, G.A. Miranda, S.A. Vaidya,
E.K. Chow, P.T. Liu, S. Suzuki, N. Suzuki, R.L. Modlin,
W.C. Yeh, et al. 2004. Toll-like receptors induce a phago-
cytic gene program through p38. J. Exp. Med. 199:81–90.
10. Alexopoulou, L., A.C. Holt, R. Medzhitov, and R.A. Flavell.
2001. Recognition of double-stranded RNA and activation of
NF-kappaB by Toll-like receptor 3. Nature. 413:732–738.
11. Kurt-Jones, E.A., L. Popova, L. Kwinn, L.M. Haynes, L.P.
Jones, R.A. Tripp, E.E. Walsh, M.W. Freeman, D.T. Go-
lenbock, L.J. Anderson, and R.W. Finberg. 2000. Pattern
recognition receptors TLR4 and CD14 mediate response to
respiratory syncytial virus. Nat. Immunol. 1:398–401.
12. Heil, F., H. Hemmi, H. Hochrein, F. Ampenberger, C. Kirsch-
ning, S. Akira, G. Lipford, H. Wagner, and S. Bauer. 2004.
Species-specific recognition of single-stranded RNA via toll-
like receptor 7 and 8. Science. 303:1526–1529.
13. Diebold, S.S., T. Kaisho, H. Hemmi, S. Akira, and E.S.C.
Reis. 2004. Innate antiviral responses by means of TLR7-
mediated recognition of single-stranded RNA. Science. 303:
1529–1531.
14. Hemmi, H., T. Kaisho, O. Takeuchi, S. Sato, H. Sanjo, K.
Hoshino, T. Horiuchi, H. Tomizawa, K. Takeda, and S.
Akira. 2002. Small anti-viral compounds activate immune
cells via the TLR7 MyD88-dependent signaling pathway.
Nat. Immunol. 3:196–200.
15. Hemmi, H., O. Takeuchi, T. Kawai, T. Kaisho, S. Sato, H.
Sanjo, M. Matsumoto, K. Hoshino, H. Wagner, K. Takeda,
and S. Akira. 2000. A Toll-like receptor recognizes bacterial
DNA. Nature. 408:740–745.
16. Akira, S., and H. Hemmi. 2003. Recognition of pathogen-
associated molecular patterns by TLR family. Immunol. Lett.
85:85–95.
17. Takeuchi, O., and S. Akira. 2002. MyD88 as a bottle neck in
Toll/IL-1 signaling. Curr. Top. Microbiol. Immunol. 270:155–167.
18. Kaisho, T., O. Takeuchi, T. Kawai, K. Hoshino, and S.
Akira. 2001. Endotoxin-induced maturation of MyD88-defi-
cient dendritic cells. J. Immunol. 166:5688–5694.
19. Kawai, T., O. Adachi, T. Ogawa, K. Takeda, and S. Akira.
1999. Unresponsiveness of MyD88-deficient mice to endo-
toxin. Immunity. 11:115–122.Requirement for TBK1 in Type I Interferon Responses 1658
20. Doyle, S., S. Vaidya, R. O’Connell, H. Dadgostar, P. Demp-
sey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and
G. Cheng. 2002. IRF3 mediates a TLR3/TLR4-specific an-
tiviral gene program. Immunity. 17:251–263.
21. Kawai, T., O. Takeuchi, T. Fujita, J. Inoue, P.F. Muhlradt, S.
Sato, K. Hoshino, and S. Akira. 2001. Lipopolysaccharide stim-
ulates the MyD88-independent pathway and results in activation
of IFN-regulatory factor 3 and the expression of a subset of li-
popolysaccharide-inducible genes. J. Immunol. 167:5887–5894.
22. Yamamoto, M., S. Sato, K. Mori, K. Hoshino, O. Takeuchi,
K. Takeda, and S. Akira. 2002. Cutting edge: a novel Toll/
IL-1 receptor domain-containing adapter that preferentially
activates the IFN-beta promoter in the Toll-like receptor sig-
naling. J. Immunol. 169:6668–6672.
23. Hoebe, K., X. Du, P. Georgel, E. Janssen, K. Tabeta, S.O.
Kim, J. Goode, P. Lin, N. Mann, S. Mudd, et al. 2003. Iden-
tification of Lps2 as a key transducer of MyD88-independent
TIR signalling. Nature. 424:743–748.
24. Yamamoto, M., S. Sato, H. Hemmi, K. Hoshino, T. Kaisho,
H. Sanjo, O. Takeuchi, M. Sugiyama, M. Okabe, K. Ta-
keda, and S. Akira. 2003. Role of adaptor TRIF in the
MyD88-independent toll-like receptor signaling pathway.
Science. 301:640–643.
25. Oshiumi, H., M. Matsumoto, K. Funami, T. Akazawa, and
T. Seya. 2003. TICAM-1, an adaptor molecule that partici-
pates in Toll-like receptor 3-mediated interferon-beta induc-
tion. Nat. Immunol. 4:161–167.
26. Fitzgerald, K.A., D.C. Rowe, B.J. Barnes, D.R. Caffrey, A. Vis-
intin, E. Latz, B. Monks, P.M. Pitha, and D.T. Golenbock.
2003. LPS-TLR4 signaling to IRF-3/7 and NF- B involves the
Toll adapters TRAM and TRIF. J. Exp. Med. 198:1043–1055.
27. Yamamoto, M., S. Sato, H. Hemmi, S. Uematsu, K. Ho-
shino, T. Kaisho, O. Takeuchi, K. Takeda, and S. Akira.
2003. TRAM is specifically involved in the Toll-like recep-
tor 4-mediated MyD88-independent signaling pathway. Nat.
Immunol. 4:1144–1150.
28. Oshiumi, H., M. Sasai, K. Shida, T. Fujita, M. Matsumoto,
and T. Seya. 2003. TIR-containing adapter molecule (TI-
CAM)-2, a bridging adapter recruiting to toll-like receptor 4
TICAM-1 that induces interferon-beta. J. Biol. Chem. 278:
49751–49762.
29. Peters, R.T., and T. Maniatis. 2001. A new family of IKK-
related kinases may function as I kappa B kinase kinases. Bio-
chim. Biophys. Acta. 1471:M57–M62.
30. Fitzgerald, K.A., S.M. McWhirter, K.L. Faia, D.C. Rowe, E.
Latz, D.T. Golenbock, A.J. Coyle, S.M. Liao, and T. Mania-
tis. 2003. IKKepsilon and TBK1 are essential components of
the IRF3 signaling pathway. Nat. Immunol. 4:491–496.
31. Sharma, S., B.R. tenOever, N. Grandvaux, G.P. Zhou, R. Lin,
and J. Hiscott. 2003. Triggering the interferon antiviral response
through an IKK-related pathway. Science. 300:1148–1151.
32. Bonnard, M., C. Mirtsos, S. Suzuki, K. Graham, J. Huang,
M. Ng, A. Itie, A. Wakeham, A. Shahinian, W.J. Henzel, et
al. 2000. Deficiency of T2K leads to apoptotic liver degener-
ation and impaired NF-kappaB-dependent gene transcrip-
tion. EMBO J. 19:4976–4985.
33. Chin, A.I., P.W. Dempsey, K. Bruhn, J.F. Miller, Y. Xu,
and G. Cheng. 2002. Involvement of receptor-interacting
protein 2 in innate and adaptive immune responses. Nature.
416:190–194.
34. Shioda, T., Y. Hidaka, T. Kanda, H. Shibuta, A. Nomoto,
and K. Iwasaki. 1983. Sequence of 3,687 nucleotides from
the 3  end of Sendai virus genome RNA and the predicted
amino acid sequences of viral NP, P and C proteins. Nucleic
Acids Res. 11:7317–7330.
35. Liou, H.C., W.C. Sha, M.L. Scott, and D. Baltimore. 1994.
Sequential induction of NF-kappa B/Rel family proteins
during B-cell terminal differentiation. Mol. Cell. Biol. 14:
5349–5359.
36. Doyle, S.E., R. O’Connell, S.A. Vaidya, E.K. Chow, K.
Yee, and G. Cheng. 2003. Toll-like receptor 3 mediates a
more potent antiviral response than Toll-like receptor 4. J.
Immunol. 170:3565–3571.
37. Honda, K., S. Sakaguchi, C. Nakajima, A. Watanabe, H.
Yanai, M. Matsumoto, T. Ohteki, T. Kaisho, A. Takaoka, S.
Akira, et al. 2003. Selective contribution of IFN-{alpha}/
{beta} signaling to the maturation of dendritic cells induced
by double-stranded RNA or viral infection. Proc. Natl. Acad.
Sci. USA. 100:10872–10877.
38. Tojima, Y., A. Fujimoto, M. Delhase, Y. Chen, S. Hata-
keyama, K. Nakayama, Y. Kaneko, Y. Nimura, N. Mo-
toyama, K. Ikeda, et al. 2000. NAK is an IkappaB kinase-
activating kinase. Nature. 404:778–782.
39. Pomerantz, J.L., and D. Baltimore. 1999. NF-kappaB activa-
tion by a signaling complex containing TRAF2, TANK and
TBK1, a novel IKK-related kinase. EMBO J. 18:6694–6704.
40. Shimada, T., T. Kawai, K. Takeda, M. Matsumoto, J. Inoue,
Y. Tatsumi, A. Kanamaru, and S. Akira. 1999. IKK-i, a
novel lipopolysaccharide-inducible kinase that is related to
IkappaB kinases. Int. Immunol. 11:1357–1362.
41. Sakaguchi, S., H. Negishi, M. Asagiri, C. Nakajima, T. Mi-
zutani, A. Takaoka, K. Honda, and T. Taniguchi. 2003. Es-
sential role of IRF-3 in lipopolysaccharide-induced inter-
feron-beta gene expression and endotoxin shock. Biochem.
Biophys. Res. Commun. 306:860–866.
42. Sato, S., M. Sugiyama, M. Yamamoto, Y. Watanabe, T.
Kawai, K. Takeda, and S. Akira. 2003. Toll/IL-1 receptor
domain-containing adaptor inducing IFN-beta (TRIF) asso-
ciates with TNF receptor-associated factor 6 and TANK-
binding kinase 1, and activates two distinct transcription
factors, NF-kappaB and IFN-regulatory factor-3, in the Toll-
like receptor signaling. J. Immunol. 171:4304–4310.
43. Honda, K., S. Sakaguchi, C. Nakajima, A. Watanabe, H.
Yanai, M. Matsumoto, T. Ohteki, T. Kaisho, A. Takaoka, S.
Akira, et al. 2003. Selective contribution of IFN-alpha/beta
signaling to the maturation of dendritic cells induced by dou-
ble-stranded RNA or viral infection. Proc. Natl. Acad. Sci.
USA. 100:10872–10877.
44. Hoebe, K., E.M. Janssen, S.O. Kim, L. Alexopoulou, R.A.
Flavell, J. Han, and B. Beutler. 2003. Upregulation of co-
stimulatory molecules induced by lipopolysaccharide and
double-stranded RNA occurs by Trif-dependent and Trif-
independent pathways. Nat. Immunol. 4:1223–1229.
45. Diebold, S.S., M. Montoya, H. Unger, L. Alexopoulou, P.
Roy, L.E. Haswell, A. Al-Shamkhani, R. Flavell, P. Borrow,
and C. Reis e Sousa. 2003. Viral infection switches non-plas-
macytoid dendritic cells into high interferon producers. Na-
ture. 424:324–328.
46. Katze, M.G., Y. He, and M. Gale, Jr. 2002. Viruses and inter-
feron: a fight for supremacy. Nat. Rev. Immunol. 2:675–687.